Frontier Pharma - Small Cell Lung Cancer: Diverse First-in-Class Pipeline Shows Promise of Targeted Therapies to Treat Aggressive Disease

  • RnM3818116
    • |
  • 24 October, 2019
    • |
  • 55 Pages
    • |
  • GlobalData
    • |
  • Pharma & Healthcare

Check Discount on this report



Purchase this Report

$6,995.00
$13,990.00
$20,985.00
5,519.06
11,038.11
16,557.17
6,638.26
13,276.51
19,914.77
1,091,989.45
2,183,978.90
3,275,968.35
590,867.65
1,181,735.30
1,772,602.95
Credit card Logo

Reports and Markets

mcafree

Contact Us

+1-352-353-0818 (US)

info@reportsandmarkets.com

Support

EMAIL US

Newsletter

KEEP UP TO DATE ON ALL THE LATEST REPORTS


maxmind_logo